UBS Group
MDXG icon

UBS Group’s MiMedx Group MDXG Stock Holding History

UBS Group’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-65,000
Closed -$568K – 7870
2016
Q1 		$568K Buy
+65,000
New +$540K ﹤0.01% 3680
2015
Q1 		– Sell
-500
Closed -$6K – 9112
2014
Q4 		$6K Buy
+500
New +$4.94K ﹤0.01% 8837

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

UBS Group's MDXG Position: Q1 2026 in Review

UBS Group increased its MiMedx Group (MDXG) stake by 153% in Q1 2026, buying an estimated $2.05M and bringing the position to 673,002 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #4707.

UBS Group first reported a position in MDXG in Q4 2014 and has held it in 38 quarters since. The position peaked at $5.29M in Q1 2018. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • UBS Group held 673,002 shares of MiMedx Group worth $2.66M as of Q1 2026.
  • UBS Group bought 406,825 MiMedx Group shares in Q1 2026, an estimated $2.05M.
  • MiMedx Group made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4707 holding.
  • UBS Group first reported a position in MiMedx Group in Q4 2014 and has held it in 38 quarters since.
  • UBS Group's MiMedx Group position peaked at $5.29M in Q1 2018.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.